Looks like a few of our STT friends may have exited. The NOM shouldn't be too far away if they want the acquisition done by end of year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025